作者 | 草履虫编辑 | 郑瑶据公开资料，2025年第二季度，全球生物医药行业一级市场融资事件数同比下降41.1%，融资总额同比下降28.3%，不少明星项目也陷入“B轮死”的尴尬。然而，真正的猎手善于在寂静中寻找机会，将子弹射向那些能穿越周期、定义未来的硬核地带。01肿瘤：放弃重磅炸弹，聚焦技术平台2025年，推动药企收购或BD交易的动因已从追求短期收入增长的“重磅炸弹”药物，转向构建长期技术能力...
Source Link作者 | 草履虫编辑 | 郑瑶据公开资料，2025年第二季度，全球生物医药行业一级市场融资事件数同比下降41.1%，融资总额同比下降28.3%，不少明星项目也陷入“B轮死”的尴尬。然而，真正的猎手善于在寂静中寻找机会，将子弹射向那些能穿越周期、定义未来的硬核地带。01肿瘤：放弃重磅炸弹，聚焦技术平台2025年，推动药企收购或BD交易的动因已从追求短期收入增长的“重磅炸弹”药物，转向构建长期技术能力...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.